Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...
The restructuring arrives during a period of turmoil at South San Francisco-based 23andMe, which has recently included a high ...
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
The genetic testing firm will also close its drug development arm. CEO Anne Wojcicki said the cuts are necessary to “focus on ...
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback